[ad_1]
The timing this week for Pfizer Inc. CEO Albert Bourla’s sale of approximately $ 5.6 million in company stock – the same day he announced positive results from his Covid vaccine – 19 – attracts the attention of some investors.
Mr Bourla sold about 60% of his personal holdings in Pfizer on Monday, joining some senior executives from other drugmakers seeking Covid-19 vaccines, including Moderna Inc. and Novavax Inc., which sold in large quantities actions after promising news. on their own coronavirus vaccines, as well as on …
[ad_2]
Source link